Portland State University

PDXScholar
Dissertations and Theses

Dissertations and Theses

5-10-1979

Ascorbic Acid, Lipid Peroxidation, and Aging
Brian Evan Leibovitz
Portland State University

Follow this and additional works at: https://pdxscholar.library.pdx.edu/open_access_etds
Part of the Biochemistry Commons, and the Biology Commons

Let us know how access to this document benefits you.
Recommended Citation
Leibovitz, Brian Evan, "Ascorbic Acid, Lipid Peroxidation, and Aging" (1979). Dissertations and Theses.
Paper 2902.
https://doi.org/10.15760/etd.2896

This Thesis is brought to you for free and open access. It has been accepted for inclusion in Dissertations and
Theses by an authorized administrator of PDXScholar. Please contact us if we can make this document more
accessible: pdxscholar@pdx.edu.

1·---··-1

I
I
I

AN ABSTRACT OF THE THESIS OF Brian Evan Leibovitz for
the Master of Science in Biology presented MaylO, 1979.

Title:

Ascorbic Acid, Lipid Peroxidation, and Aging.

APPROVED BY MEMBERS· OF THE THESIS COMMITTEE:

David T. Clark, Chairman

Malcolm Lea

Leonard Simpson

Ron.; :.~.-r(

V • .......... '""'=''"" ~

The role of ascorbic acid with regard to lipid
peroxidation and aging has been examined.

A thorough

literature analysis indicates that free radical-induced
lipid peroxidation is a plausible biochemical explana-
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tion for aging.

Lipid peroxidation causes cellular

damage due to altered enzyme activities, error-prone
nucleic acid metabolism, and membrane dysfunction, as
well as the accumulation of aging pigments in the lysosomes.

Ascorbic acid, a water soluble free radical

quencher, was examined with regard to carbon tetrachloride-induced lipid peroxidation and
aging.

..!.!! .Y.lYE

Carbon tetrachloride, a well-known free

radical inducer, caused marked increases in the ratio
of oxidized/reduced vitamin C only in the organs which
metabolize carbon tetrachloride to the free radical
form.

Vitamin C treatment, 250 mg% in the drinking

water, reduced the extent of carbon tetrachlorideinduced- lipid peroxidation.

Aging is associated with

marked increases in the ratio of oxidized/reduced
vitamin C in all organs examined with the exception
of thymus.

In organs exposed to high oxygen tensions,

or in those exposed to high levels of free radicals,
the ratio of oxidized/reduced vitamin C exceeded the

l!l

vitro ratio, indicating extensive lipid peroxida-

tion.

Vitamin C treatment reduced the extent of

lipid peroxidation
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~

of oxidized/reduced vitamin

as determined by the ratio
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CHAPTER I
INTRODUCTION
A current explanation for aging at the biochemical level is based on the production of free
radicals with subsequent free radical chain reactions leading, ultimately, to membrane damage and
cross-linking of biomolecules.

The net result is

a decline in cellular integrity caused by reduced
enzyme activities, error-prone nucleic acid metabolism, damaged membrane functions, and accumulation of •aging pigments• in lysosomes.

Ascorbic

acid (vitamin C) is a water soluble free radical
quencher, and thus possesses potential for retardation of the aging process.

Studies described

herein pertain to the role of vitamin C as a free
radical quencher using the murine model system.

-·-----

I
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CHAPTER II
REVIEW OF THE LITERATURE
The initiating event in most biological free
r•dical reactions is the production of superoxide
radical

C0 2 •)(SOR),

which is formed from molecular

oxygen by addition of a single electron (Figure 1).
SOR is acted upon by superoxide dismutase (SOD)
yielding hydrogen peroxide, which is capable of
reacting with another molecule of SOR to produce
a more potent radical, the hydroxyl radical
(Figure 1).

SOR-mediated decomposition of hydrogen

peroxide is catalyzed by ferric ion (Haber-Weiss
reaction).

The subject of the biology of oxygen

radicals has been treated in a number of recent
reviews ( 1-3).
Respiring cells are a major source of SOR,
in spite of tight binding of oxygen by cytochrome
oxidase.

The extent of SOR production during res-

piration in eukaryotes is not known.

However, in

extracts of Streptococcus faecalis in which SOD
activity had been inhibited by specific antibody,
a total of 17 percent of the oxygen consumed

-- ---
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(electron transport, drugs, >
enzymes, pollutants, radiation)

(SOR)

Oz)· {2H+
superoxide
dismutase .

o2
H20~

H202

(hydrogen
peroxide)

2 G~

GSSG
H0
2

~SH

)0·

peroxidase

Fe-+++

Haber-Weiss
Reaction
02
OH- +OH·

(hydroxyl
radical)
Figure I. Production of superoxide radical, hydroxyl radical,
and hydrogen peroxide.
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resulted in
SOR

SOR

production (4).

The importance of

production during respiration was demonstrated

by Loschen et al. (5), who found that the production

I

of hydrogen peroxide was tightly coupled to energy

I

conservation in rat liver mitochondria.

I

sociation of

SOR

The as-

production and respiration has led

to the suggestion that the mitochondrionis the
nmolecular clock" in eukaryotic systems, and that
the maximal life span of a species is related to
the rate of oxygen consumption (6).

In this regard,

low oxygen concentrations have been shown to extend
the life span of cultured human diploid cells in
vitro (7).
Respiration is not the only source of SOR,
however, and its production has been demonstrated
to be associated with, or required for, the
activity of a number of enzymes, including xanthine
oxidase, aldehyde oxidase, flavin dehydrogenase,
diamine oxidase, and ribulose-1,S-diphosphate
carboxylase (1,8,9).

SOR production has also been

shown during the autooxidation of a variety of
molecules, including hydroquinones, flavins,
catecholamines, tetrahydropterins, ferrodoxins,
and hemoglobin (1,10,11,12,13).

The autooxidation

of various chemicals, including herbicides (paraquat),
medicines (adriamycin), and alkyl halides (carbon
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tetrachloride) also produce SOR (14-18).
One consequence of free radicals is the production of lipid peroxides.

Free radical attack

on polyunsaturated fatty acids yields lipid radicals
with allylic double bonds, which may add to molecular oxygen to produce lipid peroxy radicals,
which by abstraction of a proton and-electron
ultimately produce lipid peroxides (Figure 2).
Lipid peroxides are known to decompose and yield
a variety of products, including ethane, pentane,
and various aldehydes.

The most important al-

dehyde produced is malondialdehyde (CHO-cH 2 -CHO),
which forms Schiff base cross-links with amines
of proteins, phospholipids, and nucleic acids.
The product of this reaction is a biomolecule
many times the size of the original,.which because
of unusual bonds, is not digested in the lysosome
and accumulates there with age.

These biopolymers

are fluorescent, with a characteristic excitation
maxima at 360-380 nm, and an emission maxima at
440-470 nm.

The accumulation of these pigments,

termed aging pigments, ceroid, or lipofuscin, is
directly related to the age of the animal (19,20).
The Schiff base products of the condensation of
malondialdehyde with the primary amines of proteins,

.....-. ...... .-.-.
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R-CH•CH-CH -R

<electron and
abstraction)

:rOic;';z+

~

R-CH•CH-CH-R

(allylic PUFA radical)

I
02

R-CH•CH1H-R

Uipid peroxy radical)
LH

R-CH•CH-~ -R

(PUFA alcohol)

GSH

L·

peroxidase

R-CH•CH1:-R

soonta~

lipid oeroxtde
~
decomposition products
(malondialdehyde, ethane, pentane)

Figure 2. Free radical-induced lipid peroxidatlon.

<lipid hydroperoxide)

1·--·---·---· ---· -

................. _ _

&

__

I

I
I
1

7

nucleic acids, or phospholipids has fluorescent
properties similar to those observed for native
lipofuscin (21).

Further, peroxidation of sub-

I

cellular organelles (lysosomes, mitochondria, and

\

microsomes) .......
in vitro results in the formation of

I

aging pigments with spectra similar to that of
native lipofuscin (22).
The significance of lipid peroxidation and
cross-linking is the reduction in cellular integrity caused by such events.

Lipid peroxides have

been noted to inactivate various enzymes, including
isocitrate dehydrogenase (23), and to activate
potentially damaging enzymes, such as guanylate
cyclase (24).

Lipid peroxidation damages integrated

membrane functions, the best example being the inhibition of oxidative phosphorylation of rat liver
mitochondria by methyl linoleate hydroperoxide (25).
Lipid peroxidation causes an increased

rat~Q

of

oxidized/reduced glutathione (via glutathione
peroxidase), which may inactivate important regulatory enzymes, such as adenylate cyclase (26),
as well as decreasing the amount of transcriptionally active genetic material (27).
Although free radicals are ubiquitous, they
are by no means omnipotent.

Elaborate enzymatic
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systems have been evolved by aerobic organisms to

l

reduce the fluxes of SOR and hydrogen peroxide, which
in turn will reduce the production of hydroxyl radicals

I

(Figure 1).

Superoxide dismutase (SOD) is the major

I

defense system which protects against elevations in

I

the levels of SOR.
of two

molecu~es

SOD catalyzes the dismutation

of SOR to yield hydrogen peroxide

and molecular oxygen (Figure 1).

Hydrogen peroxide,

while less toxic than either SOR or hydroxyl radical,
is nevertheless damaging to biological systems, and
I

must therefore be detoxified.

Glutathione peroxidase

I
I

utilizes thei reducing power of glutathione

ci

-L-

i

glutamyl-L-cysteinylglycine) to reduce hydrogen
peroxide to water (Figure 1), and contains selenium
as a coordinating mineral.

Glutathione peroxidase

also acts on lipid peroxides, reducing these to
fatty acid alcohols (28).

Glutathione peroxidase

reacts with a wide variety of lipid hydroperoxides,
and is specific for the hydroperoxyl group and not
for attached alkyl or aryl groups (28).
Ascorbic acid appears to play a protective
role against free radical damage.

Ascorbic acid

has been shown to be oxidized by SOR generated from
a xanthine-xanthine oxidase system, with a second
order rate constant of 2.7 x 10 5 M-1 sec -1 (29).
cellular pH, the rate constant for the reaction

At

I
I
I
I
I

9

between SOR and SOD is about 8 x 10 8 M-1 sec -1 {l),
or about 3,000 times faster than the ascorbate-

1

catalyzed reaction.

The level of SOD in most tissues,

however, is approximately 10- 6 M, about 1000 times
less than the approximate concentration of ascorbic
acid (29).

The actual rate of reaction between SOR

and SOD is, therefore, only about 3 times that for
the ascorbate-catalyzed reaction, which indicates
that ascorbic acid may play a supplementary role
against SOR-mediated toxicity.

In support of this

protective role of ascorbic acid, the production of
SOR by guinea pig macrophages .!.!! vitro was inhibited
by various antiinflammatory agents
ascorbic acid (30).

including

Ascorbic acid has also been shown

to quench the hydroxyl radical (31).
Ascorbic acid may play a primary role as an
extracellular defense against free radicals in such
tissues as the lung, where approximately SO percent
of the ascorbic 'acid is found in the fluid lining of
the respiratory epithelium in the rat (32) and the
guinea pig (33).

Scorbutic guinea pigs have been shown

to maintain the extracellular pool of ascorbic acid in
the lung, and in fact, the percentage of extracellular
ascorbic acid increases from 57 percent in controls to
78 percent in the scorbutic guinea pig (33).

Thus,

1·

I
I
I

even in scurvy, a substantial proportion of the lung

I

vitamin C is found in the respiratory lining in spite

I
I
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of an overall decrease in lung ascorbic acid content.
This is of considerable interest in that enzymatic
defense systems including SOD and glutathione per-

I

I

oxidase are found only intracellularly, and would not
be available for reaction with extracellular free
radicals or oxidants.
The toxicity of ozone and oxygen is due to promotion of free radical reactions (34), and ascorbic
acid (as well as other antioxidants) has been shown
,to protect against oxidant damage.

Ascorbic acid was

found to be particularly effective against lung

~amage

in rats exposed to 4-5 atmospheres of oxygen, while
its effect on prolonging surv1val in mice exposed
to 5 atmospheres of oxygen was less striking (35).
Vitamin C also decreased mortality in mice exposed
to various concentrations of ozone, and was responsible for a decrease in pulmonary edema which follows
such exposure (36).
Dietary ascorbic acid has also been shown to
reduce the extent of lipid peroxidation in both the
mouse (37) and the guinea pig (38).

In the latter

study, dietary ascorbic acid increased the level of
vitamin E in the plasma of vitamin E-def icient guinea
pigs, which indicates an important nutritional inter-

,--· 6---- I

I
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I

relationship with respect to free radical quenchers.

I

Ascorbic acid has also been demonstrated to reduce
mortality due to carbon tetrachloride in the rat (15).

I

I
I
I'
i

This is of considerable interest in that carbon tetrachloride is a well known free radical inducer, and
studies_described herein explore the role of ascorbic
acid in carbon tetrachloride-induced lipid peroxidation.
A

curious feature of the molecular biology of

ascorbic acid is that very low concentrations appear
to induce lipid peroxidation in brain and liver microsomes in vitro, while higher, physiologic concentrations prevent such peroxidation (39-41).

The mechanism

of this effect is that ascorbic acid can reduce ferric
ion to the ferrous state, which can then catalyze
the decomposition of hydrogen peroxide to the hydroxyl
radical, as in the Haber-Weiss reaction (Figure 1).
The observed inhibition of lipid peroxidation at

higher concentrations of ascorbic acid is probably
due to its free radical quenching action.

Despite

this 1.!l vitro induction of lipid peroxidation by
ascorbic acid, no evidence has been presented for
the production of free radicals by ascorbic acid
either

.!.!!

~

or

.!.!!

vitro.

Halliwell and Foyer (42)

have shown that the autooxidation of ascorbic acid
does not generate SOR.

Reaction of ascorbic acid

I
I
I

I
I

.. 12
with free radicals produces a partially oxidized form
of ascorbate known as the ascorbate free radical (AFR),
which may react with another radical to produce de~y~reascorbate

(Figure 3).

It is theoretically

possible that AFR itself may initiate free radical
chain reactions:

however, it has been demonstrated

that AFR is not reactive with a variety of intermediary metabolites, does not react with oxygen, and
quenches itself extremely rapidly (43).

Further,

an enzyme system has been isolated from rat liver
which catalyzes the reduction of AFR to ascorbic
acid (NADH: semidehydroascorbate oxidoreductase)
(Figure 3), which should further lessen the possibility of AFR-induced lipid peroxidation (44).
The complete oxidation of ascorbic acid to the
dehydroascorbate form results in the quenching of
two moles of free radicals per mole of ascorbate
oxidized.

Reduced glutathione reacts directly

with dehydroascorbic acid and results in the formation of ascorbic acid, which may provide an effective recycling system for ascorbic acid-mediated
free radical quenching (45).

Ascorbic acid also

reacts directly with hydrogen peroxide, and may
be an ancillary mechanism to protect against toxicity
due to various hydroperoxides (46).

Ascorbic acid

13

L" ':: d'LH

ascorbic
acid

::;::.

0

H~

H--OH
1
oll--1H 0H
2

H-OH
CH 0H
2

ascorbate free
radical

L·

dehydroascorbate
reductase

LH

dehydroascorbic
acid
Figure 3. Ascorbic acid and free radical quenching.
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I

appears, therefore, to be a molecule which may quench

\

I

free radicals without leading to further free radical
production, and may thus play a protective role against

I
I

--

free radical reactions in vivo.
The ability of antioxidants to quench free

I

radical reactions should, theoretically, lead to

I

enhanced longevity, but to date_ very few investigations of this nature have been reported.

Harman

(47) first reported that synthetic antioxidants,
when added to the diets of mice, were able to extend
the life span.

Addition of 2-mercaptoethylamine

(2-MEA) (1.0%), cysteine HCl (1.0%), or 2,2'-diaminodiethyldisulfide dihydrochloride (0.5%) increased the half survival time of AKR mice by approximately 20%.

In a subsequent study by Harman

(48), antioxidants were shown to prolong the life
span of both AKR and C3H mice.

2-MEA (1.0%) was

very effective in this regard, and resulted in an
increase of 26% in the mean life span of C3H mice.
Hydroxylamine HCl showed a slight effect on longevity, increasing the mean lifespan of C3H mice by
about 7%.

In the AKR strain, cysteine HCl (1.0%)

and hydroxylamine HCl (1.0%) increased the half
,

~

survival time by about 15%.

Harman (49) has also

reported that addition of synthetic antioxidants

I
I
I
l
I

I
I
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to the diet of LAF 1 mice reduced the rate of mortality.
2-MEA resulted in a dose-dependent increase in mean

lifespan;

at 0.5% an increase of 12.8% in the mean

lifespan was noted, and at 1.0% an increase of 29.3%
was observed.

Butylated hydroxytoluene, at 0.5% of

the diet, increased the mean lifespan of LAF 1 mice
by 45%. A pilot study on the effect of ascorbic acid
on the lifespan of guinea pigs has been reported
by Davies et al. (50).

Guinea pigs given 1.0% L-

ascorbic acid in the drinking water showed no increase
in mean lifespan compared to guinea pigs given 5 mg
ascorbic acid per kilogram body weight (by oral
intubation).

These results are difficult to in-

terpret, however, since the high and low vitamin C
groups received ascorbic acid by different routes
of administration.

I

I
I
I
I
CHAPTER III

I
I

MATERIALS AND METHODS
MICE

I

Mice used in these studies were of the following strains:

BALB/c, DBA/2, NZB, BALB/c x DBA/2

F 1 hybrids, and BALB/c x NZB F 1 hybrids.

BALB/c and

DBA/2 breeding stocks were obtained from Jackson
Laboratory, Bar Harbor, Maine.

NZB breeding stocks

were obtained in 1966 from the Otago University
Medical School, Dunnadin, New Zealand.

All mice

used in these studies were bred in our own colony
from stocks described above.
DIETS
All mice were maintained on Purina Rodent chow
(Ralston-Purina Co., Saint Louis, Mo.), which was

-----

given ad libitum.
ceived tap water

Mice not given vitamin C re-

!s!

libitum.

Vitamin C-treated mice

received tap water containing 250 mg% L-ascorbic acid
_!2 libitum.

This regimen of 250 mg% L-ascorbic acid

in the drinking water resulted in a daily intake of
about 400.11JRg .. ascorbic acid per kilogram body weight.
Ascorbic acid-containing water was stored in brown
;'

17
bottles, and changed every other day in order to
avoid oxidation.

CHEMICALS
2,4-dinitrophenylhydrazine was obtained from

u.s.

Biochemical Corporation, Cleveland, Ohio.

Thiourea was obtained from Sigma Chemical Company,
Saint Louis, Missouri.

Cupric sulfate was pur-

chased from Matheson, Coleman and Bell Company,
Cincinnati, Ohio.

Carbon tetrachloride was obtained

from Malinckrodt Inc., Saint Louis, Missouri.

All

chemicals used in these studies were reagent grade.
PREPARATION OF REAGENTS
The 2,4-dinitrophenylhydrazine-thioureacupric sulfate (OTC) mix was prepared as follows:
1.00 g
g

of 2,4-dinitrophenyl hydrazine, 0.125
of thiourea, and 0.01S g

of cupric sulfate

were added to SO ml of 9 N H so , stirred on a mag2 4
stirrec~

and filtered through a sintered glass

filter funnel.

The DTC mix thus obtained was stored

netic

at 2°

c,

and was prepared every week.

The 2,4-di-

nitrophenylhydrazine-thiourea (DT) mix was prepared
as follows:
and 0.250 g

1.00

t

of 2,4-dinitrophenylhydrazine

of thiourea was added to SO ml of

--
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9 N H

2

so 4 ,

stirred with a magnetic

stirrer~

and fil-

tered through a sintered glass filter funnel.

DT mix was stor@d at 2°
week.

The

c, and was prepared every

65% sulfuric acid was prepared by adding

560 ml of concentrated sulfuric acid to 240 ml of distilled water.

9

N

sulfuric acid was prepared by

I

adding 300 ml distilled water to 100 ml of concentrated sulfuric acid.
TISSUE PREPARATIONS
Blood was obtained by orbital sinus puncture,
allowed to clot at room temperature for 10 minutes,
and centrifuged at 2,000 rpm for 10 minutes in an
International centrifuge (model HN).

Serum thus

obtained was diluted with 9 volumes cold 103 trichloroacetic acid (TCA) and mixed thoroughly.
Tissues were removed immediately following exsanguination, weighed on a Mettler H6 electronic
balance, and homogenized in 9, 19, 39, or 79 volumes
of cold 10% TCA, depending on the weight of the
tissue.

Total volumes of TCA homogenates were be-

tween 3 and 8 ml.

Samples were centifuged at 3,000

rpm for 10 minutes in a PR-2 International refrigerated centLifuge, and the supernatants pipetted into
a 13 x 100 mm borosilicate test tube.

Aliquots of

r--

·--H-• ..

I

I
1

I
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the protein-free

supernat~nt

were used immediately
tota~

for determination of oxidized and

vitamin

c,

as described below.
ASSAY OF TOTAL VITAMIN C
Total vitamin C levels were determined by the
Lowry (51) modification of the method of Roe and
Keuther (52).

400 pl of the protein-free super-

natant was added to labeled 13 x 100 mm borosilicate
test tubes, followed by addition of 130 pl of the OTC
mix.

All samples were run in triplicate.

vortexed, and incubated in a 37
exactly four hours.

0

Tubes were

C water bath for

Samples were then placed in an

ice bath, and 670 pl of 65% sulfuric acid was added.
Samples were vortexed, and color development allowed
to proceed at room temperature for 45 minutes.

Per-

cent transmittance was recorded on a Beckman model

B spectrophotometer at 520 nm.
from

Blanks weee prepared

400 pl of 10% TCA plus all reagents;

standards were prepara::l from 400

pl

of a 0.2 mg/100

ml ascorbic acid solution plus all reagents.

Ascorbic

acid standards (1.0 mg/ml) were prepared in batch and
frozen at -20°

c,

and on the day of assay, were dil•

uted 1:500 (volume:volume) with 10% TCA, to yield the
working standard (0.2 mg ascorbic acid/100 ml).

I
I
I
l
I
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ASSAY OF OXIDIZED VITAMIN C
Oxidized vitamin C was determined essentially

I

by the method of Stevenson and Brush (53).

I

were prepared exactly as for determination of total
vitamin

c,

Samples

except that 130 pl of the DT mix was added

instead of the DTC mix.

The exclusion of cupric

sulfate from the DT mix prevented the oxidation of
the ascorbic acid, and therefore results obtained
with this procedure yielded values of "oxidized"
vitamin C (dehydroascorbic acid and 2,3-diketogulonic acid).

Since ascorbic acid is easily ox-

idized, even in 10% TCA, all

samples to be assayed

for oxidized vitamin C were incubated in the DT mix
within 30 minutes

after cervical dislocation.
CALCULATIONS

Percent transmittance was converted to absorbance using standard tables from the Handbook
of Analytical Chemistry.

Both total and oxidized

vitamin C levels were calculated in the following
manner:
Absorbance (unknown)
Absorbance (standard)

x D

=

mg/100 grams wet
weight
or mg/100 ml serum

Homogenization volumes of 9,19,39, and 79 required

21
use of 2, 4, 8, and 16 for the D factor, respectively.
Values were obtained for both total and oxidized

vitamin

c, and reduced vitamin C levels

were cal-

culated by subtraction.
STATISTICAL ANALYSIS
Analysis of the data obtained was performed
on a Monroe programmable computer, using the student
•t• test.

P values of greater than 0.05 were con-

sidered insignificant.
EXPERIMENTAL PROTOCOLS
Baseline Studies
DBA/2 and BALB/c mice were taken at various ages,
and their tissues and serum vitamin C levels determined as described above, in order to determine the
effect of age on tissue and serum vitamin C levels
in the mouse.

Mice used for baseline studies were

not given supplemental ascorbic acid.

Groups of from

3-11 mice were used.
In Vitro Oxidized/Reduced Ratio
In order to determine the equilibrium between
oxidized and reduced vitamin C _!n vitro, 25 mg ascorbic acid was dissolved in 100 ml of 0.1 M phosphate

22

buffer, pH 7.4, and the time course of its oxidation
followed during incubation in a 37

0

C water bath.

Total and oxidized vitamin C levels were assayed as
described above.
In Vivo Oxidized/Reduced Ratio
These studies were designed in order to determine the effect of age on the ratio of oxidized/reduced vitamin C in tissues of mice not given supplemental ascorbic acid.

Mice were sacrificed at

various ages, as described in the results section,
and tissues prepared and assayed for total and oxidized vitamin C as described above.

Groups of 4

to 7 mice were utilized.
Effect 6f Vitamin C On In Vivo Oxidized/Reduced Ratios
This experiment was carried out in order to
determine the effect of supplemental ascorbic acid
on the ratio of oxidized/reduced vitamin C

.!.!!

vivo.

BALB/c female mice, 15 months of age, were employed
in this study.

The vitamin

C-tre~ted

group were

placed on a regimen of 250 mg% L-ascorbic acid in
the drinking water at 3

mon~hs

group received tap water.

of age ;

the control

Serum and tissues were

prepared and assayed for total and oxidized vitamin
C as described above.

group.

Four mice were used in each

l

I

I
I

I
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Time Course ef CC1 -Induced Lipid Peroxidation
4
Carbon tetrachloride (CC1 > is a well known
4
lipid peroxidizer, and it was of interest to determine the time course of

cc1 4 -induced

lipid peroxida-

tion, as determined by the ratio of oxidized/ reduced
vitamin

c.

For this experiment, BALB/c x DBA/2 F 1

male hybrids, 7 to 9 months of age, were employed.
No supplemental ascorbic acid was given.

Groups of

4 to 5 mice were injected intraperitoneally with 0.05
ml of

cc1 4 ,

and were sacrificed at 1, 2, and 3 days

post-injection. Four :mice served as controls, and
were not treated with

cc1 4 •

Liver, kidney, and spleen

were removed following cervical dislocation, and total
and oxidized vitamin C determined as described above.
Spleen weights and hematocrits were also obtained
since

cc1 4

is known to effect these parameters.

Effect Of Ascorbic Acid en CC1 -Induced
4
Lipid Peroxidation
The effect of supplemental ascorbic acid on

cc1 4 -induced

lipid peroxidation was determined using

BALB/c x NZB F 1 males, 10 to 12 months of age.

Four-

teen control mice, and 14 vitamin C-treated mice, were
injected with

o.os

ml

cc1 4

intraperitoneally, and sac-

rificed two days post-injection.

Vitamin C-treated

24

mice had been on the ascorbic acid regimen for 5
weeks prior to cc1

4 injection.

Liver, kidney, and

spleen were removed following cervical dislocation;
and total and oxidized vitamin C determined as
described above.

l
I

CHAPTER IV
RESULTS
EFFECT OF AGE ON TOTAL VITAMIN C LEVELS IN
BALB/c AND DBA/2 MICE
The effect of age on the levels of vitamin C in
serum, liver, and spleen for DBA/2 and BALB/c mice is
shown in Table I.

In the DBA/2 strain, males as well

as females manifested depressed serum levels with advancing age, approximately 35% over a period of 27
months.

BALB/c mice also displayed decreases in serum

vitamin C levels with advancing age,

41~

over a 28

month period in females and 54% in males after 8
months, the last month available in our colony.
terestingly, both DBA/2 and

BALBI~

mice showed

In~ajor

depressions of serum vitamin C levels during the first
two months of life, which parallels the decline in
liver vitamin C levels during this age period.
Another depression in serum vitamin C occurred in
DBA/2 females at 14 months of age and in BALB/c
females at 21 months.

DBA/2 males continued to show

a relatively steep decline up to 8 months, mainly
leveling off ·thereafter.

1

I
I
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I
'l'AIL£ I
EFP'EC'l'

or

AGE ON TOTAL VITAMIN

IN TWO INBRED STRAINS
Strain
and setc

(mo.)

DBA/2

1

females

2

Age

4

14
21
27

Nu11ber
of aiee

2.67.:.0.25
2.30.!,0.04
1.95,:0.06
1.83.!,0• 21
1.76_:0.18
1.86.!,0• 33

35. 7.!1.22
22.8.!,1.98
22.6.!,0.44
23.0.:.0.09
23.8.!,0.62
22.8.!,0.49
18.6.!,0.88

42 .o.!o. 2e
44.4.!,2.44
47.6.!,4• 78

2.41.!.0.06
2.12_:0.06
2.01,:0.09
2.08.!,0.11
1.39_:0.06
1.42,!0.03

35.5.!,1.03
27.1.!,0.55
27.2.!,1.14
19.6_:0.83
19.9.!,0.99
18. 5_:0.64

31. 7.!,1.03
32.4!,1.13
45.6_:1. 95
43.5.!2.20
44.4.!,0.98
46.4!,2.04

3. 25.!,0.16
1.90_:0.10
1.83.!,0.20
1. 51,:0.06

27.4.!1.33
21.6.!, 1.04
22.0.!,2.06
15.3,:0.98

29. 3.:.0.93
38.1_:1.00
39.6_:1.45
40.0.!,1.22

1

s
4

8

6
3
4
4
5

1

7

2

6
8

16
20
23
28
BALB/e

111ales

8

9
3

1

6

2
6

9
5
5

8

a
Vitamin C Cmg/100 grams)&S.E.M.
serum
Liver
seteen
35.0.:.1.40
31.8.!,1.48
20. 7.!,0• 32
17.8.:.0.37
15.8+0.58
-b

2

females

LEVELS

2. 78.:.0.06
2.42.!,0.04
2.86.:.0.06
2.83.!,0.48
2.09.:.0.09
1.76.!,0.18

DBA/2

BALB/e

c

RICE

11
6
4
5
5
4

11ales

9
13
27
29

or

n.d.

n.d.

28.8.:.1.21
41. 3,!1.17
38.1.!,1. 36
41.o.:.3.20
40.6,!1.24
49.5.!,2.10
27.4.!1.14
34. 7.!1.40
34 .6.:.1.46

n.d.

• Values expressed •• •9 vitamin C per 100 •l ••rum and mg vitamin
wet weight of liver and spleen.
b Not determined.

C per 100 grams

1

I

27

I

I

Liver vitamin C levels were observed to decrease
in both the DBA/2 and BALB/c strains with advancing
age.

DBA/2 females showed a 55% reduction in liver

vitamin C over a period of 21 months, while DBA/2 males
exhibited a 48% reduction in 29 months.

Similar re-

sults were obtained with BALB/c mice, in which females showed a 48%

reduction and males a 44% re-

duction over a period of 28 and 8 months, respectively.
In both the DBA/2 and BALB/e strains, very high liver
vitamin C levels of the order of 27-35 mg/100 grams
wet weight of tissue were observed at 1 month of age,
suggesting extensive synthesis of ascorbic acid.
In the case of the spleen there was marked
accumulation of vitamin C with aging in the DBA/2
and BALB/c strains, the steepest rise occurring from
1 to 2 months of age.

In the DBA/2 strain, females

exhibited a 72% increase, and males a 74% increase,
during 27 and 29 months of life, respectively.

In

the BALB/c strain, females showed a 46% increase,
and males a 36% increase, during 28 and B months of
life, respectively.

RATIO OF OXIDIZEDJREDUCED VITAMIN C IN VITRO
The results of this experiment are shown in
Figure 4.

The ratio of oxidized/reduced vitamin C

l
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increased from a value of 0.05 at 1 minute to 0.56
at 180 minutes, after which there was no further

increase.

These data demonstrate that ascorbic acid

is oxidized under simulated physiological condidtions
to an.!.!! vitro equilibrium ratio of 1:2 (oxidized:
reduced).
ker for

l!!

This

l!!

vitro ratio will be used as a mar-

,:!.!Y.2 studies, in which the ratio is noted

to increase during aging and during carbon tetrachloride-induced lipid peroxidation.
EFFECT OF AGE ON THE RATIO OF OXIDIZED/
REDUCED VITAMIN C IN VIVO
DBA/2 males
The effect of age on the ratio of oxidized/
reduced vitamin C in DBA/2 males is shown in Table
II.

In all tissues examined a significant increase

was observed in the ratio with advancing age in
liver, spleen, lung, and kidney.

Marked increases

were observed in kidney oxidized/reduced ratios,
which rose from a 2 month value of 0.12 to a 17
month value of 0.42, an increase of 3.5 fold. It
is of interest that in the lung, the ratio increased

to a value greater than the

.!!l

described above, suggesting

that the extent of lipid

vitro equilibrium ratio

peroxidation exceeds the capacity of the lung to
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TABLE II
EPPECT OP AGE ON THE RATIO OP OXIDIZED/
REDUCED VITAMIN C IN DBA/2 MALESa

Age
(mo.)
2

Ro. of
mice
5

Ratio of Oxidized/Reducf'd Vitamin C.! S.E.M.
Liver
Cung
Kldnez:
~eteen
0.10,:0.01

p (0.001
17

5

0.19,!0.01

0.33,!0.01

p (.0.001

0.49,!0.01

0.49,:0.01

p (.0.025

0.65,!0.04

0.12,!0• 01

p

<. 0.001

0.42,!0.02

a OBA/2 males, not given supplemental ascorbic acid, were maintained
as described in the text. Tissues were removed and assayed for
total and oxidized vitamin C as described in the text.

II
I

I

I
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reduce dehydroascorbic acid to ascorbic acid.
BALB/c females

The

eff~et

of age on the ratio of oxidized/

reduced vitamin C in BALB/c females is shown in
Table III, for mice aged 1, 8, and 15 months.

In

the liver, a small but significant increase was observed between 1 and 8 months, and a marked increase
observed between 8 and 15 months.

A four-fold in-

crease in the liver ratio was observed between 1 and
15 months of age.

In the spleen, a significant in-

crease was observed between 1 and 8 months, after
which there was no further rise.

The lung exhibited

a three-fold increase between 1 and 15 months, with
significant increases at all age periods studied.
The 8 and 15 month ratios of oxidized/reduced vitamin

C in the lung exceeded the

.!.!!

vitro equilibrium ratio,

suggesting extensive lipid peroxidation

.!!!

~·

Values for the thymus did not change between 1 and

8 months, and the thymus tissue was not obtainable
from 15 month-old mice due to thymic involution.

The

kidney exhibited marked increases at all age periods
examined, and showed a six-fold increase between 1
and 15 months of age.

5

4

8

15

o. 38,!0.02

p)0.2

p<0.001
0.47,!0.05

0.34,!0.02

P<0.05

p(0.005
0.16,!0.01

0.24,!0.03

0.12.!o.01

0.96,!0.04

p(0.001

0.69,!0.07

p<0.001

0.36,!0.05

0.23,!0.02

p)0.2b

0.18,!0.04

0.46,!0.04

p<o.oos

o.2e.!o.02

p<0.001

o.oa.!0.01

Ratio of Oxidized/Reduced Vitamin C ~ S.£.M.
Spleen~---Lung- -thymus
----1<I<fney

Liver

------------

for total and oxidized vitamin C

--~-

~ssayed

-----------

b P)0.05, and therefore insignificant.

in the text. Tissues were removed and
as described in the text.

a BALB/c females, not given supplemental ascorbic acid, were maintained as described

4

t

No. Of
mice

Age
(1110.)

EFFECT OF AG~ OH THE RATIO OP OXIDIZED/REDUCED
VITAMIN C IN BALB/c FEMALES 8

TABLE III

~

·--·-- ---·
-·-~

N

w

___.

l
I
I

I
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COMPARISON OF OXIDIZED/REDUCED VITAMIN C RATIOS IN
4-5 WEEK OLD BALB/c AND NZB FEMALES

The ratios of oxidi2ed/reduced vitamin C in
tissues from _4

week old BALB/c females are com-

pared to the ratios observed in 5 week old NZB
females.in Table IV.

NZB females exhibited a

significantly increased ratio in spleen, lung, and
kidney, and a significantly decreased ratio in liver,
when compared to age-matched BALB/c females.
EFFECT OF VITAMIN C-TREATMENT ON OXIDIZED/REDUCED
RATIOS IN 15 MONTH OLD BALB/c FEMALES
The effect of supplemental ascorbic acid on
tissue oxidized/reduced vitamin C ratios in 15 month
old BALB/c females is shown in Table

v.

Vitamin C-

treated mice were placed on a regimen of 250 mg% Lascorbic acid in the drinking water at 3 months of
age, while controls recieved tap water.

Vitamin C-

treated mice exhibited significantly reduced ratios
in serum, kidney, liver, spleen, and lung, while the
ratio in heart was unaffected by such treatment.
TIME COURSE OF CC1 -INDUCED LIPID PEROXIDATION
4
The time course of

cc1 4 -induced

lipid per-

oxidation is shown in Figure 5 for BALB/c x DBA/2

5

4

AQe
{weeks)

7

4

mice

No. of

0.34!.0.02

p(0.05

p(0.001

0.06!.0.01

0.24!.0.03

Spleen

Oxidized/Re~uced

0.12,!0.01

Ratio of
Liver

0.43!.0.02

p<0.025

o. 31!.0.02

Lunq

Vitamin C

p(0.05

o.oe!.0.01

S.E.M.
Kidney

0.16,!0.02

~

---

~~·

a BALB/c and NZB females, not given supplemental ascorbic acid, vere maintained ••
described in the text. Tissues were removed and assayed for total and oxidized
vitamin C as described in the text.

females

NZB

BALB/c
females

Group

COMPARISON OP OXIDIZED/REDUCED VITAMIN C RATIOS IN
4 TO 5 WEEK OLD BALB/c AND NZB PEMALE MICEa

TABLE IV

~=~-~

~·-~--

~

w

--- - - ---~.

--

4

Vlta•ln Ctreated
0.58,!0.01

p)0.5b

p(0.005

0.56,!0.01

0.58,!0.06

0.31,!0.03

p,0.025

0.46,!0.04

0.30,!0.03

p.(0.05

0.47,!0.05

0.30,!0.03

p4>.05

0.38,!0.02

Ratio of Oxidized/Reduced Vitamin C ±. S.E.M.
He1u·t
Kldney
LTver
Spleen

1.06,!0.11

Serum
~ung

0.78,!0.01

P<(>.Ot

0.96,!0.04

----

Female BALB/c mice were maintained as described in the text. Vitamin C-tteated Mice
vere placed on a regimen of 250 m~ L-ascorbic acid in the drinking water at 3 months
of aqe; controls received tap water. At 15 months of age, all mice were sacrificed
and tissues prepared and total and oxidized vitamin C assayed as described .in the text.
P')O.OS, .and therefore insignificant.

4

•
b

of
mice

No.

Control

Group

EFFECT OF VITAMIN C TREATMENT ON THE RATIO OF
OXIDIZED/REDUCED VITAMIN C IN
15 MONTH OLD BALB/c FEMALES 8

TABLE V

U1

w

--~

---~·

____,

1

I

I

I
I
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1 males injected 1.p. with a large dose of cc1 4
CO.OS ml/mouse).A presumptive estimate of lipid perox-

F

idation was determined by the vitamin C

rati~In

both

I

the liver and the kidney, significant increases in

I.

injection, with the peak ratio observed at 48 hours •

I

I

the ratio were observed at 24 and 48 hours post-

By 72 hours post-injection, the ratios appeared to
fall toward baseline values.
no effect of

cc1 4

In the spleen, however,

was noted, as the ratio remained

constant at about 0.44.

Total vitamin C levels, spieen

weights, and hematocrits for these
are shown in Table VI.

cc1 4 -treated

mice

Liver vitamin C values, ini-

tially at 17.1 mg%, fell to 8.82 at 24 hours, and 6.19
at 48 hours, and then increased to 8.22 at 72 hours.
Liver vitamin C levels in

cc1 4 -treated

mice were sig-

nificantly lower than controls at all times.

Kidney

values showed the same trends, that is,a drop in
vitamin C levels occurred at 24 and 48 hours postinjection, with a rise toward baseline values at 72
hours.

However, only the 48 hour value obtained

statistical significance in the ease of the kidney.
Spleen vitamin C levels were unaffected by
treatment.

cc1 4

Hematocrits were significantly increased,

while spleen weights were significantly decreased,
at all times following

cc1 4

administration.
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Figure 5. Time course of cct4-induced alteration in the
oxidized/ reduced vitamin C ratio In BALBI c x DBAI 2 F
1
male hybrids.
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TAat.E VI

EP'FECT or CCl4-TR!ATMENT ON TOTAL VITAMIN
C LEVELS, SPLEEN WEIGHTS, AND HEMATOCRITS
IN 7 TO 9 MONTH OLD BALB/c x DBA/2
MALE P' 1 HYBRIDS•
Time post
in1ection

No. Of Hct.
mice :,S.E.M.

Spleen Wt.
(g).!.S.E.M.

Total Vitamin C (mg~)~ S.E.M.
Liver
Kidney
Spleen

0 houi-s
(control)

4

48.8
.!,0.92

0.0980
.!,0.0100

17. 1.!, 1•0

10.4.!,0.52

34 .1.!,0.4 3

24 hours

5

61. 5
.!,2 .66

0.0659
.!,0.0070

8.82.!,1.87

9.63.!,0.Bl

35.2,!2.23

48 houi-s

4

57.6
.!, l.90

0.0557
.!,0.0170

6.19.!,0.38

4.23.!,0.45

36.0.!,l.58

72 hours

4

61.0
.!,2.04

0.0311
.!,0.0054

8.22.!,0.26

10. 3.!,0.64

33.7.!,l.83

Statistical Evaluation
24 hours
vs. controls

p(0.005

p<O .025

p(0.025

p')O. 5

p)0.5

48 hours
vs. controls

p(0.005

p<0.025

p(0.001

p(0.001

p')0.4

72 hours
vs. controls

J><0.005

p<0.005

p(0.001

p)0.5

p)0.5

a BALB/c x DBA/2 r 1 males were maintained as described in the text, without
supplemental ascorbic acid. Tissues were prepared and vitamin C assayed
as described in the text.
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EFFECT OF SUPPLEMENTAL ASCORBIC ACID ON CC1 4
INDUCED LIPID PEROXIDATION IN BALB/c x
NZB Fl MALE HYBRIDS
The effect of supplemental ascorbic acid (250
mg% in the drinking water) on cc1 -induced lipid per4
oxidation in BALBI« x RZB F
VII.

1

mal~s

is shown in Table

Ascorbic acid treatment resulted in a signific-

antly elevated level of vitamin C in the liver and
kidney, but not in the spleen of these mice.

Ascorbic

acid treatment was observed to decrease the ratio of
oxidized/reduced vitamin C in liver, kidney, and
spleen, with a 50% reduction in the ratios observed.

-·

-----------~=·

~·~·-··-~·-~

TABLE VII

···~=.,·~"~-·~···~---~~.

4

7

9

No. of
mice

13.4,!0.32

p(0.001

7.16~0.53

10.9,!0.66

p<0.005

B.16~0.49

74

36.6,!1.61

p)0.2b

34.o~1.

Total Vttamf n C (mg?'.:)...S.E.M.
Liver
Kidney
Spleen

0.25,!0.01

p<0.001

0.59~0.04

0.30,!0.01

p(0.001

o.56~o.os

0.32,!0.01

p<0.001

0.60,!0.04

Ratio of Oxidized/Reduced Vit. C±S.E.K.
Liver
K{dney
Spleen

EPPECT OP ASCO~DIC ACID TREATMENT ON TOTAL VITAMIN C LEVELS AND
RATIOS OP OXIDIZED/REDUCED VITAMIN C IN BAL3/c x NZS
F 1 MALES INJECTED WITH 0.05 ml OF CCl 8

..

BALB/c x HZB F 1 males were maintained as described in the text. Vitamin c-treated mice
were placed on a re~imen of 250 m~ L-ascorblc actd in the drinking water 5 weeks prior
to CC1 4 injection. Mlce were Jn1er.ted wlth 0.05 ml cc1 4 l.p., and sacrificed two days
post-in1ection for total and oxidized vltamtn C determinations, as described in the text.

c-

.

b P)0.05, and therefore inslqntflcant.

a

Vitamin
treated

Control

Group

---~·~·~". ·~--

0

~

CHAPTER V
DISCUSSION
AGE-RELATED CHANGES IN TOTAL VITAMIN C LEVELS
Aging in the mouse has been demonstrated to be
associated with a fall in serum and liver vitamin C
levels.

These results are in agreement with those

obtained from human and guinea pig studies.

In

humans, significant depressions have been observed
in plasma, platelet, leucocyte, and buffy coat
vitamin C levels with advancing age (54-60).

Very

little information exists on variations in tissue
vitamin C levels with age in humans, however.

Schaus

(61), in 1957, reported decreases in all tissues which
he examined, including some 70 specimens obtained
at autopsy.

A depression of 49%, 77%, 33%, and 60%

was observed for pituitary, cerebral cortex, myocardium, and pectoral muscle, respectively, between 1
and 80 years of age. .- .. Hughes and Jones ( 6 2) have investigated the effects of age on tissue vitamin C
levels in the guinea pig, and have found that older
animals showed significantly lower concentrations of
ascorbic acid in spleen, adrenal glands, and eye lens,
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with elevated levels of ascorbic acid observed in
brain.
The decrease .in serum vitamin C parallels the
drop in liver vitamin

c,

and it is likely that the

serum levels merely reflect the rate of liver synthsis
of ascorbic acid, since the serum is not a storage
organ for vitamin

c.

The drop in the rate of syn-

thesis of ascorbic acid (as evidenced by a decrease
in liver vitamin C levels) is of considerable interest
in that, in the unsupplemented mouse, the liver is
the only source of vitamin

c.

-It is possible that,

with advancing age, the transcription of genes coding for enzymes involved with ascorbic acid synthesis
declines.

No evidence, however, has been presented

to support this contention.

Lipid peroxides have

been shown to decrease the rate of ascorbic acid
synthesis (63), suggesting that an increase in lipid
peroxidation would shut off vitamin C synthesis.
Since lipid peroxidation is known to increase with
advancing age (19,20), it is very likely that the
observed decrease in liver vitamin C levels is secondary to an increase.in liver lipid peroxidation.
A vicious cycle could then ensue, in which lipid
peroxidation causes a decrease in the vitamin C
biosynthetic rate, which reduces the amount of

l/
1·
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ascorbic acid available for quenching free radical
reactions, which would lead to enhanced lipid perThis cycle of events may, in

oxidation.

pa~t,

account

for the observed increase in the accumulation of aging
pigments with advancing age.
In the spleen, the marked accumulation of vitamin C

observed in these studies may represent either

a storage mechanism for vitamin

c,

or may represent

an increased requirement of the spleen for vitamin C
with advancing age4

The spleen is a highly oxidative

organ due to its content of phagocytes, which produce
superoxide radical during intracellular killing, and
it is possible that the storage of vitamin C observed
in the mouse is in response to oxidative damage mediated by neutrophils and macrophages.

In either case,

the spleen accumulates vitamin C in spite of a drop
in liver and serum levels, .indicating that an active
transport system (or facilitated transport system),
~perating

against a concentration gradient, must be

functioning.
those

~ttained

These results are not in accord with
in the guinea pig (62), in which a

decrease in vitamin C was· observed with age.

These

differences may reflect species specific variances
in vitamin C seq~estered by the spleen,

or

may simply reflect variances in the serum levels
of vitamin

c.
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RELIABILITY OF THE RATIO OF OXIDIZED/REDUCED
VITAMIN C AS AN ASSAY FOR LIPID PEROXIDATION
The cc1

experiments were performed in order
4
to evaluate the reliability of the ratio of oxidized/
reduced vitamin C as an assay for lipid peroxidation.

cc1 4 was chosen because it is the most standard experimental technique for inducing lipid peroxidation

(64).

cc1

4

is metabolized exclusively in organs

containing the microsomal cytochrome P-450 system,
and the initiating event has been suggested to be the
homolytic cleavage of the cc1 -c1 bond, causing a
3

trichloromethyl radical Ccc1 •) to be formed (65).
3
This causes free radical-mediated lipid peroxidation
in the microsomal lipids surrounding cytochrome P-450,
with chain reactions leading to lipid peroxidation
in much of the liver cell membranes.
oxidation caused by cc1

4

Lipid per-

causes an inhibition in

the secretion of lipoproteins and triglycerides,
which results in the characteristic fatty liver
of cc1 -treated animals (66).

4

Lipid peroxidation should result in an increase
in the ratio of oxidized/reduced vitamin C by the
following mechanism:

1 ipid peroxides'\('

GSH ' \

lipid alcohols...-''+GSSG _,)

?'

dehydroascorbate

'-ascorbic acid

1
I
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I

The observed increase in liver and kidney oxidized/
reduced ratios (Figure 5) suggests this mechanism,

and strongly suggests that this ratio may be useful
as an estimation of 'lipid peroxidation in

~·

Since lipid peroxidation is known to increase with
advancing age (19,20), the determination of oxidized/
reduced vitamin C ratios may represent a novel estimation of aging.
At no time was the spleen ratio effected by

cc1 4

treatment.

This is in accord with present

knowledge concerning the metabolism of

cc1 4

in

that the spleen, lacking a cytochrome P-450 system,
is not involved in

cc1 4

metabolism, and therefore no

change in the ratio of oxidized/reduced vitamin C is
observed.
the

This tissue specificity demonstrates that

cc1 4 -induced

increase in the ratio in liver and

kidney is not a result of non-specific toxicity, but
possibly of tissue specific free radical-induced
lipid peroxidation.
It is of interest that during

cc1 4

treatment,

the kidney evidenced a dramatic increase in the
oxidized/reduced ratio at 24 hours post-injection,
despite no change in· .the total vitamin C concentration
at that time (Table VI).

This finding indicates that

the change in the ratio is due to a drop in the level

46

of reduced vitamin

c,

which suggests that reduced

vitamin C is either being utilized in order to

cc1 4 ,

quench free radicals .. produced by

or is being

utilized to reduce GSSG (oxidized glutathione), in
order to accelerate the glutathione peroxidasemediated lipid peroxide quenching activity.

In

either case, reduced vitamin C is being consumed
as a defense against

cc1 4 -induced

lipid peroxida-

tion.
Total vitamin C decreases in liver and kidney
(at 48 hours) suggesting metabolism of vitamin C
beyond the 2,3-diketogulonic acid stage.
of effect 0£

cc1 4

The lack

on spleen total vitamin C is

further proof of tissue specificity.

Of interest

is the finding that, in spite of a marked drop in
spleen weights (Table VI}, spleen vitamin C concentrations remained constant.

Previously, an

inverse relationship between spleen weight and
spleen vitamin C was found (67), and it was expected that, as the spleen weights decreased following

cc1 4 ,

the spleen vitamin C would increase.

The finding that

spl~en

vitamin C remained constant

indicates a reduction in the amount of vitamin C
per spleen, and this suggests that the spleen may
be playing the role of a storage organ, capable of
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donating its vitamin C to other organs when the need
arises.
These results, taken together, indicate that
the ratio of oxidized/reduced vitamin C is a sensitive
indicator of lipid peroxidation

.!.!:!

~'

and may

therefore be applied to other situations involving
lipid peroxidation.
peroxidation

~as

This novel estimation of lipid

technical advantages over existing

methods, which involve laborious histological examinations, electron microscopy, or extraction of
tissues with toxic organic solvents (68).

The ratio

of oxidized/reduced vitamin C is a sensitive assay
(note standard error of the .. mean in Tables II, III,
IV,V, and VII), is reliable from day to day, does
not require use of organic solvents, and is relatively easy to perform•

This ratio has advantages over

existing methods in that it theoretically measures
both lipid peroxidation as

~ell

as cytosolic free

radical damage, whereas lipofuscin, ethane, pentane,
or malondialdehyde measure only lipid peroxidation,
and as has been mentioned, free radicals are produced
in the cytosol by numerous enzymes, drug autooxidations, and x-irradiation.

Further, the for-

mation of aging pigments reflects only oxidative
damage because of a lack of degradation of these

l
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pigments

lE,

~'

whereas the ratio of oxidized/

reduced vitamin C reflects both oxidative damage as
well as reductive capacity of the cell.

The signif i-

cance of this lies in the fact that lipofuscin accumulation is a unidirectional process, while the
ratio of oxidized/reduced vitamin C is a steadystate condition, which is more likely to reflect
the current extent of oxidative damage and repair
in the cell.
APPLICATION OF THE RATIO OF OXIDIZED/REDUCED
VITAMIN C TO IN VIVO AGING
Assuming that the ratio of oxidized to
reduced vitamin C reflects lipid peroxidation in a
model system, it was of interest to determine the
effect of age on

l.!l

~

ratios.

These experiments

were carried out in two different strains of mice,
in order to be certain that the results were not
merely a strain anomaly.

The results (Table II,

Table III) indicate an age-associated increase in
the ratio of oxidized/reduced vitamin C in all tissues examined, except in the thymus, and except in
the spleen of BALB/c females between 8 and 15 months
of age.

The increase in the ratio was often dramatic:

the liver ratio role 4 fold, and the kidney ratio 6

l
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fold, in BALB/c females between 1 and 15 months of
age.
It is of interest that organs exposed to the
most oxidative damage yielded the highest ratios.
Thus the lung, exposed to chronic high oxygen tensions, showed the highest ratios of oxidized/reduced
~

vitamin C in all tissues examined,with the exception
of serum.

Lung ratios frequently exceeded the in

vitro equilibrium ratio of 0.55,

suggesting that

lipid peroxidation was proceeding to a greater extent than the reductive capacity of the lung.

For

example, a ratio of 0.96 was observed for lung tissue from 15 month old BALB/c females, which is well
above the

lD.

vitro equilibrium ratio.

Serum oxidized/reduced ratios were the highest
observed for any tissue (Table S), demonstrating that
vitamin C transported in the serum is approximately
50% in the oxidized form.

Thus, tissues are exposed

to a large amount of oxidized vitamin

c,

which is

the form of vitamin C absorbed preferentially by
such

cells

as leucocytes and erythrocytes (69).

The high serum ratios do not reflect free radical
activity, but rather a lack of reductive capacity
of this tissue.
An organ exhibiting high oxidized/reduced

50
ratios is the spleen, which is exposed to oxidative
damage due to superoxide radical production during
intracellular killing in macrophages and granulocytes.

Spleen values were generally higher than

those observed in liver, kidney, or thymus, but did
not exceed the

.!.!:!.

vitro equilibrium ratio of 0.55.

The lack of increase in the spleen ratio of BALB/c
females between 8 and 15 months is very important,
because during

t~is

period the spleen accumulates

vitamin C dramatically (Table I).

It is possible

that the increased vitamin C content of the spleen
at this age period provides protection against free
radical-induced lipid peroxidation.
Kidney and liver oxidized/reduced ratios, initially low at 1 to 2 months of age, increased dramatically with advancing age, particularly with regard to the kidney.

However, ratios did not exceed

the l!!, vitro equilibrium ratio of 0.55, suggesting
that cellular reductive capacity was at least equivalent to cellular oxidative damage.
Of interest is the observation that ratios of
oxidized/reduced vitamin C in heart tissue (Table V)
were greater than the

.!!!

vitro equilibrium ratio,

suggesting extensive lipid peroxidation in that .
organ.

This is in agreement with present knowledge

l
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on lipid peroxidation in cardiac muscle, in that
heart contains the highest number of mitochondria
per cell of any organ, and accumulates aging pigments
to a greater extent than any other organ except brain
and testes (68).
Thymus is the only organ which did not show
age-associated changes in the oxidized/reduced ratio.
This is likely due to the low level of oxidative
processes which occur in the thymus.

T-lympho-

cytes do not produce much superoxide radical, and
there are no phagocytes located in the thymus.

Thus,

the ratio of oxidized/reduced vitamin C may be an
indicator of cellular aging only in those tissues
which exhibit oxidative metabolism, or are exposed
to oxygen or to superoxide radical.
Finally, the ratios of oxidized/reduced vitamin
C in the lung are higher than published values for
the ratio of oxidized/reduced glutathione in the
lung of the rat (70), which was observed to be 0.06.
This would indicate that the ascorbic acid-dehydroascorbic acid system is a backup redox system for a
more important

functio~

namely the GSSG/GSH

rati~

wht:h

regulates enzymatic activities, genetic transcription,
and the enzyme glutathione peroxidase.

It would be

of interest to determine age-related alterations in
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the ratio of GSH/GSSG in animal tissues in order to
determine the relationship between the GSH/GSSG system and the oxidized/reduced vitamin C ratio.
Further work should extend these studies on
the effect of age on the ratio of oxidized/reduced
vitamin C to other

species~

including humans.

It

is possible that in the future, an assay for aging
based on this ratio may be routinely applied to
human

cells,

such as leucocytes, which are

readily available and which store vitamin C to
a much greater extent than does serum.
THE NZB MOUSE AS A MODEL FOR RAPID AGING
A comparison of the ratios of oxidized/reduced
vitamin C between NZB and BALB/c female mice (Table
IV) demonstrates significant increases in the ratio
in the spleen, lung, and kidney of NZB females.

In

the liver, however, NZB's exhibited a significantly
lower ratio than their BALB/c counterparts.

These

results suggest that lipid peroxidation is occurring
at an elevated rate in NZB tissues (except for liver),
which is of considerable interest in that the NZB
mouse is a model for rapid aging and autoimmune disease.

The mean. lifespan of NZB mice in our laboratory

is about 14 months, which is half that for mice of
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the BALB/c strain, and it is conceivable that the
accelerated aging in the NZB mouse is caused by an
elevated rate of oxidative damage.

In this regard,

we have previously shown that NZB mice between 16
and 20 months of age.have significantly lower vitamin C levels in spleen, liver, and serum compared
to either BALB/c or DBA/2 mice (67).

Further,

NZB mice do not accumulate vitamin C in their spleens
with advancing age (67), as was demonstrated for
BALB/c and DBA/2 mice (Table I).

These data,

taken together, indicate that lowered vitamin C
levels in the NZB may be, in part, responsible
for the accelerated aging phenomenon, and that
the ratio of oxidized/reduced vitamin C appears
to reflect this rapid aging.

The decrease in liver

oxidized/reduced ratios, which would suggest a lower
rate of lipid peroxidation, is not in accord with
data obtained for the other organs.

The reason

for this discrepancy is currently unknown.

EFFECT OF ASCORBIC ACID-TREATMENT ON LIPID
PEROXIDATION DURING AGING AND DURING
CC1 4 ADMINISTRATION
Assuming that the ratio

of oxidized to

reduced vitamin C is a reliable indicator of lipid
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peroxidation (and therefore aging), it was of interest
to examine the possible protective effect of ascorbic

acid agAinst ageparameter.

a~d

CC1 4 -induced increases in this

With regard to aging, the experiment was

designed in order to evaluate the effect of longterm ascorbic acid treatment (13 months out of 15
months of life) on

.!!!

vivo lipid peroxidation.

These results (Table V) indicate that ascorbic acid
treatment reduced the extent of oxidative damage in
all organs examined except the heart.

These data

suggest that the aging process may be retarded by
dietary antioxidant treatment, as has been amply
demonstrated for vitamin E and selenium, as well
as various synthetic antioxidants, including butylated hydroxytoluene and 2-mercaptoethylamine (see
Chapter II).

The lack of effect of ascorbic acid

treatment on ratios in heart may be due to the low
storage capacity of the heart for vitamin

c.

Zannoni (71) has found that heart contains the
lowest amount of vitamin C of any of the 10 organs
studied, with the exception of plasma.

Spleen, for

example, contains 9 times the amount of vitamin C
found in heart (71).

Since lipid peroxidation has

been implicated as a risk factor in coronary heart

1
55
disease (72), the value of dietary ascorbic acid
supplements in the management of this condition
appears dubious.
One potential criticism of this protocol is
that dietary ascorbic acid may artificially effect
the ratio of oxidized/reduced vitamin

c.

In depth

examination, however, reveals that this criticism
is not of significance.

In the serum, which sup-

plies the organs with vitamin C, a significant
fraction of the vitamin C is in the oxidized form,
and in fact, in the serum of animals not supplemented with ascorbic acid, the ratio of oxidized/
reduced vitamin C is about 1:1.

Even during asc-

orbic acid supplementation, the ratio is still high,
about 1:2, indicating that tissues are receiving a
relatively large amount of oxidized vitamin

c.

Further, it has been demonstrated that oxidized
vdtamin C is preferentially taken up by such cells
as lymphocytes, granulocytes, and erythrocytes (69,
73), rather than the reduced form.

Inside these

cell types, the amount of reduced vitamin C depends
on the activity of the enzyme dehydroascorbate reductase (73).

It is of interest

tha~

the ability of

granulocytes to withstand ionizing radiation has been
attributed to their high levels of dehydroascorbate

l
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uptake and reduction {73), when compared to the
radiosensitive lymphocyte.

Also of interest is

the fact that, despite our precautions with the
preparation and storage of vitamin C-containing
water, a considerable proportion {about 30%) of
the ascorbic acid is oxidized before it is consumed by the mice.

It is unlikely, therefore,

that the ascorbic acid treatment should artifactually lower the ratio of oxidized/reduced
vitamin

c.

However, as an added precaution, ex-

periments are now in progress to determine the
effect of selenium and vitamin E supplements on
the ratio of oxidized/reduced vitamin C in vivo,
since any decrease in the ratio due to selenium
or vitamin E treatment is definitely a result of
a decrease in lipid peroxidation {both selenium and
vitamin E have been observed to reduce lipid peroxidation in numerous animal studies).
The results of this aging study, if they are
confirmed, present the possibility of a reduction in
the rate of aging by dietary

antioxi~ants,

which has

tremendous implications for human nutrition.

The

ultimate proof would reside in studies on the effect
of vitamin C on longevity.

These studies are similar

in nature to those discussed in Chapter II, in which
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an extension of the mean life span was observed for
mice fed synthetic antioxidants.

With regard to cc1 4 intoxication, administration
of ascorbic acid resulted in a significant protective
effect against cc1 -induced lipid peroxidation (Table
4
VII). Ascorbic acid treatment reduced the extent of
lipid peroxidation by approximately 50% in both liver
and kidney.

The spleen ratio was also reduced dra-

matically by ascorbic acid treatment, but since it
was previously determined that the spleen was unaffected by cc1 4 , this decreased ratio probably
reflects the reduction in age-associated lipid peroxidation in the spleen, as was shown for the spleen
of BALB/c females given long-term supplements of
ascorbic acid (Table V).

It is of great interest

that even though the total vitamin C levels in the
spleen were not affected by ascorbic acid treatment,
the ratios of oxidized/reduced vitamin C decreased
dramatically_(Table VII), indicating that the ratio
is not merely reflective of the total vitamin C
concentration of the organ, but rather reflective of
the extent of oxidative damage.
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